Journal article
A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 594.8KB, Terms of use)
-
- Publisher copy:
- 10.1038/s41408-021-00545-w
- Publication website:
- http://minerva-access.unimelb.edu.au/bitstream/11343/287889/1/PMC8417099.pdf
Authors
- Publisher:
- Springer Nature [academic journals on nature.com]
- Journal:
- Blood Cancer Journal More from this journal
- Volume:
- 11
- Issue:
- 9
- Pages:
- 149-149
- Article number:
- 149
- Publication date:
- 2021-09-03
- DOI:
- EISSN:
-
2044-5385
- ISSN:
-
2044-5385
- Language:
-
English
- Keywords:
- Pubs id:
-
1195733
- Local pid:
-
pubs:1195733
- Source identifiers:
-
W3196556572
- Deposit date:
-
2026-03-26
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2021
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record